Listed by the USPTO as NICOL, ALEXANDER W
Tech Center 1600 • Art Units: 1633 1634
This examiner grants 43% of resolved cases
NICOL, ALEXANDER W works in tech center 1600 and art unit 1633. The profile covers 178 resolved cases, with an allowance rate of 42.7%. The median time to allowance is 1512 days. Interview lift is 43.6%, making interviews a prominent feature of the reported prosecution outcomes.
The recurring applicants are The Regents of the University of California, Krystal Biotech Inc., and Julius-Maximilians-Universität Würzburg. The listed firms are BAKER BOTTS L.L.P., PA - BOZICEVIC FIELD & FRANCIS LLP, and WENDEROTH, LIND & PONACK, L.L.P. Practitioners can use the combination of the allowance, timing, and interview figures to plan engagement, while the applicant and firm lists identify relevant experience for this examination record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18065255 | SILENCING OF DUX4 BY RECOMBINANT GENE EDITING COMPLEXES | Non-Final OA | University of Massachusetts |
| 18685591 | PRODUCTION OF CELLULAR PRODUCTS BY CELLS EMBEDDED IN A HYDROGEL MATRIX | Non-Final OA | Centre National de la Recherche Scientifique |
| 18538799 | THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | The Regents of the University of California |
| 18279199 | LENTIVIRUS PROTECTION VIA Fc OVEREXPRESSION | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17169442 | COMPOSITIONS AND METHODS TO BARCODE BACTERIOPHAGE RECEPTORS, AND USES THEREOF | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17616111 | NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY | Non-Final OA | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 17244136 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18282463 | CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS | Final Rejection | Brown University |
| 17152463 | ADENO-ASSOCIATED VIRAL VECTOR, COMPOSITIONS, METHODS OF PROMOTING MUSCLE REGENERATION, AND TREATMENT METHODS | Non-Final OA | NEW YORK UNIVERSITY |
| 18276812 | ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES | Final Rejection | Wake Forest University Health Sciences |
| 18737396 | SEQUENTIAL APPLICATION OF MACROPHAGES FOR WOUND HEALING | Non-Final OA | Drexel University |
| 18394085 | CELL PREPARATION METHOD | Final Rejection | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.7% of resolved applications examined by Alexander W Nicol were allowed (178 resolved cases), compared with 34.8% across Art Unit 1633 over the last five years.
This examiner's interview lift is +43.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Alexander W Nicol took 1,512 days on average from filing to allowance.
Alexander W Nicol examines applications in Art Unit 1633 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
